TGFBR1 and chronic kidney disease: These results suggested that during CKD, TβRI overexpression exerted an additive effect on decreased bone formation, as seen in a reduced osteoblast surface and increased bone resorption, as seen in increasing of osteoclast surface resulting in severe bone loss.